QUALITATIVE AND QUANTITATIVE COMPOSITION
Per dose of 1 ml:
Lyophilisate:
Active substances:
Live attenuated feline calicivirus (strain F9) 104.6–106.1 CCID50*
Live attenuated feline viral rhinotracheitis virus (strain F2) 105.0–106.6 CCID50*
Live attenuated feline panleucopenia virus (strain LR 72) 103.7–104.5 CCID50*
* Cell culture infectious dose 50%.
Suspension:
Active substance:
Minimum quantity of purified p45 FeLV-envelope antigen 102 μg
Adjuvants:
3% aluminium hydroxide gel expressed as mg Al3+ 1 mg
Purified extract of Quillaja saponaria 10 μg
Excipients:
Qualitative composition of excipients and other constituents |
Lyophilisate: |
Gelatin |
Potassium hydroxide |
Lactose monohydrate |
Glutamic acid |
Potassium dihydrohgen phosphate |
Dipotassium phosphate |
Water for injections |
Sodium Chloride |
Disodium phosphate |
Suspension: |
Sodium chloride |
Disodium chloride |
Potassium dihydrogen phosphate |
Water for injections |
Aluminium hydroxide gel |
Visual appearance:
Lyophilisate: White color.
Suspension: Opalescent liquid.